Focus and Scope
Pharma Deals Review is a journal that delivers relevant analyses on deals within the pharmaceutical and biotechnology industry worldwide. It examines industry issues and their impact on the deal making environment.
The Journal analyses specific deals and reports on trends and developments within deal-making in different technology and therapy areas. It also publishes articles based on the analyses of data presented in PharmaDeals v4 Agreements database, as well as many other sources of information available to our expert team of writers.
Pharma Deals Review is read by professionals in the life sciences industry involved in business development, licensing, finance, law, marketing, and by healthcare professionals working in deal making. The journal is also of interest to researchers in academic institutions and business schools, to lawyers and investment analysts, as well as to media professionals.
Section Policies
CompiledPDFs
Research & Development
Licensing
Mergers & Acquisitions
Joint Venture
Business Commentaries
Distribution & Marketing
Cartoons
Deal Trackers
Features
General
Company Profile
Royalties
Editorial
Conference Report
Technology Access
Opinion & Analysis
Pharma Deals Review
Pharma Deals Review is a rapid communications publication that delivers instant, relevant articles and analyses on deal making. It examines industry issues and examines their impact on the deal making environment.
Pharma Deals Review is read by professionals in the life sciences industry involved in business development, licensing, finance, law, marketing, and by healthcare professionals working in deal making. The journal is also of interest to researchers in academic institutions and business schools as well as to media professionals.